Clin2
NCT05583942Possibly a fitRecruiting

Nerve stimulation trial for children with steroid-resistant kidney syndrome

Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis

Part of Kidney & urinary, Women’s health & pregnancy clinical trials.

This pilot study tests a device that stimulates nerves in the ear to help children with steroid-resistant nephrotic syndrome. It may improve urine protein and kidney-related outcomes for kids whose standard steroid treatment does not work.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
10 people
Ages
3 years to 17 years
Study type
Interventional

Who can take part

  • Child is ages 3–17
  • Nephrotic syndrome does not go into remission after 4 weeks of standard-dose prednisone
  • Kidney function is enough for the study (eGFR 30 or higher)
  • Kidney biopsy shows minimal change disease or focal segmental glomerulosclerosis
  • Urine protein is still high (urine protein:creatinine ratio over 1.0)
  • Uses stable anti-inflammatory medicines and an ACE inhibitor or ARB for at least 3 months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05588063Recruiting
Device-based nerve stimulation for relapse-preventing kidney disease in kids

This trial tests whether a small non-surgical device can help keep children with steroid-sensitive nephrotic syndrome in remission. If it works, it could lower the chance of relapse (kidney flare-ups) and help maintain kidney health.

New Hyde Park, New York
NCT06079788Recruiting· Phase 3
ACTH for children with frequently relapsing nephrotic syndrome

This trial tests if a hormone called ACTH can help children with nephrotic syndrome who have frequent relapses or need steroids to stay in remission. It aims to find a treatment that may reduce the need for steroids and prevent relapses.

Wuhan, Hubei
NCT07087314Recruiting· Phase 2
Study of an injection for nephrotic syndrome in children

This study tests an injection (SG301) that targets a protein called CD38 to help children whose nephrotic syndrome keeps coming back or depends on steroids. The goal is to see if the treatment can reduce relapses and the need for steroids.

Hangzhou, Zhejiang
NCT07091175Recruiting· Phase 2
Dupilumab for nephrotic syndrome in children

This trial tests if dupilumab can help children with nephrotic syndrome who still have relapses despite standard treatments. It aims to find a better way to control the disease and reduce steroid side effects.

Singapore, Singapore
NCT05981183Recruiting
Vagus nerve stimulation for chronic kidney disease

This study tests a device that gently stimulates a nerve in your ear to see if it can help people with chronic kidney disease (CKD). The device is non-invasive and may improve how your body handles kidney-related issues.

New York, New York
NCT06987565Recruiting· Phase 2
Nerve stimulation device for lupus pain

This trial tests whether a non-invasive nerve stimulation device worn on the ear can help reduce pain and inflammation in people with lupus. It may be an option if you have moderate to severe muscle or joint pain and are not on certain medications that were recently started.

Manhasset, New York

Hear when a new Nephrotic Syndrome in Children trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.